CLINICAL_TRIALS
trial_result
· 2013-12-10
Clinical Trial Update: Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma [NA]
Summary
A clinical trial update reports on a rapid 90-minute rituximab infusion protocol for non-Hodgkin lymphoma; trial status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National University Hospital, Singapore | Conditions: Non Hodgkin Lymphoma | NA | Status: COMPLETED